Open AccessExpression of MUC2 and MUC4 proteins and cytokines: early markers of intestinal graft rejection1,2
Author(s) -
Nir Wasserberg,
Shashikumar K. Salgar,
Dinghua Yang,
Phillip Ruiz,
Samuel B. Ho,
Werviston L. De Faria,
S. Santiago,
Carlos Gandia,
Joshua Miller,
Yaron Niv,
Andreas G. Tzakis
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000060566.34001.ca
Subject(s) - mucin 2 , mucin , immunosuppression , tacrolimus , medicine , tumor necrosis factor alpha , immunohistochemistry , h&e stain , pathology , transplant rejection , immunology , transplantation , gastroenterology , biology , gene expression , gene , biochemistry
Histopathologic examination (HP) is the primary method of monitoring intestinal graft rejection. Alterations in mucin levels have been demonstrated in bowel diseases. The aim of this study was to detect early markers of intestinal graft rejection based on mucin and cytokine levels.